| 1 |
35455441 | Synthetic Design and Biological Evaluation of New p53-MDM2 Interaction Inhibitors Based on Imidazoline Core. | 2022 Apr 2 |
4 |
| 2 |
31781989 | Simulation of MDM2 N-terminal domain conformational lability in the presence of imidazoline based inhibitors of MDM2-p53 protein-protein interaction. | 2020 Jan |
1 |
| 3 |
31196710 | 2,4,5-Tris(alkoxyaryl)imidazoline derivatives as potent scaffold for novel p53-MDM2 interaction inhibitors: Design, synthesis, and biological evaluation. | 2019 Aug 15 |
2 |
| 4 |
31478534 | Organocatalytic diastereoselective [3+2] cyclization of MBH carbonates with dinucleophiles: synthesis of bicyclic imidazoline derivatives that inhibit MDM2-p53 interaction. | 2019 Sep 19 |
1 |
| 5 |
21855354 | Design, synthesis, and biological evaluation of imidazoline derivatives as p53-MDM2 binding inhibitors. | 2011 Sep 15 |
2 |
| 6 |
17897804 | Exploration of liquid and supercritical fluid chromatographic chiral separation and purification of Nutlin-3--a small molecule antagonist of MDM2. | 2007 Dec 21 |
1 |